600535 Share Price Performance
CN¥0
-16.26 (-100.00%)
Price CN¥0
Share Pricen/a
Tasly Pharmaceutical Group Co., Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
600535 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Tasly Pharmaceutical Group Co., Ltd Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Aug 22, 2026
- 0.82
- 66.34%
- 15.01%
- 8.9%
About 600535
- Founded
- 1994
- Employees
- 10563
- CEO
- WebsiteView website
Tasly Pharmaceutical Group Co., Ltd, together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China. The company offers prescription drugs covering various therapeutic areas, including cardiovascular-cerebrovascular, tumor immunity, digestion and metabolism, and neuroscience; over-the-counter drugs; modern TCM; biological drugs; and chemical drugs. It also engages in medical instruments, agriculture, and chain drugstore activities. The company was formerly known as Tianjin Tasly Pharmaceutical Co., Ltd. and changed its name to Tasly Pharmaceutical Group Co., Ltd in May 2012. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is headquartered in Tianjin, China.
